{"nct_id":"NCT00820924","title":"Study of Lapatinib in Breast Cancer Patients With HER-2 Non-amplified Primary Tumors and HER-2 Positive or EGFR Positive Circulating Tumor Cells","status":"TERMINATED","status_verified_date":"2012-03","start_date":"2008-06","start_date_type":null,"primary_completion_date":"2011-07","primary_completion_date_type":"ACTUAL","completion_date":"2011-07","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["GSK"]}